Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9341924rdf:typepubmed:Citationlld:pubmed
pubmed-article:9341924lifeskim:mentionsumls-concept:C0330390lld:lifeskim
pubmed-article:9341924lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:9341924lifeskim:mentionsumls-concept:C0001473lld:lifeskim
pubmed-article:9341924lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:9341924lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:9341924lifeskim:mentionsumls-concept:C0038477lld:lifeskim
pubmed-article:9341924lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:9341924lifeskim:mentionsumls-concept:C0597484lld:lifeskim
pubmed-article:9341924lifeskim:mentionsumls-concept:C0682002lld:lifeskim
pubmed-article:9341924lifeskim:mentionsumls-concept:C0243072lld:lifeskim
pubmed-article:9341924pubmed:issue21lld:pubmed
pubmed-article:9341924pubmed:dateCreated1997-11-28lld:pubmed
pubmed-article:9341924pubmed:abstractTextA series of digitalis-like compounds, with the lactone ring shifted from the original position through a spacer or replaced by a series of guanylhydrazone substituent-bearing chains, was synthesized and evaluated for inhibition of Na+,K(+)-ATPase and for inotropic activity. The highest Na+,K(+)-ATPase inhibition (IC50) and inotropic activity (EC50) were reached with the vinylogous guanylhydrazone 5 where a cardenolide-like polarized alpha,beta-unsaturated system and a basic guanidino group were both present at the 17 beta-position; for this compound IC50 and EC50 values were comparable to or higher than those of Thomas' parent guanylhydrazone 1, digitoxigenin, and digoxin. A substantial improvement of the desired positive inotropic activity versus the toxic arrhythmogenic concentration was not reached within this series; only a slightly better therapeutic index can be envisaged for compounds 5 and 4, even though, for the latter, to the detriment of potency, presumably because of a weaker interaction with the receptor, due to the lack of a cardenolide-like polarized system.lld:pubmed
pubmed-article:9341924pubmed:languageenglld:pubmed
pubmed-article:9341924pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9341924pubmed:citationSubsetIMlld:pubmed
pubmed-article:9341924pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9341924pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9341924pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9341924pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9341924pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9341924pubmed:statusMEDLINElld:pubmed
pubmed-article:9341924pubmed:monthOctlld:pubmed
pubmed-article:9341924pubmed:issn0022-2623lld:pubmed
pubmed-article:9341924pubmed:authorpubmed-author:FerrariPPlld:pubmed
pubmed-article:9341924pubmed:authorpubmed-author:MelloniPPlld:pubmed
pubmed-article:9341924pubmed:authorpubmed-author:SerraFFlld:pubmed
pubmed-article:9341924pubmed:authorpubmed-author:CerriAAlld:pubmed
pubmed-article:9341924pubmed:authorpubmed-author:PadoaniGGlld:pubmed
pubmed-article:9341924pubmed:authorpubmed-author:FolpiniEElld:pubmed
pubmed-article:9341924pubmed:issnTypePrintlld:pubmed
pubmed-article:9341924pubmed:day10lld:pubmed
pubmed-article:9341924pubmed:volume40lld:pubmed
pubmed-article:9341924pubmed:ownerNLMlld:pubmed
pubmed-article:9341924pubmed:authorsCompleteYlld:pubmed
pubmed-article:9341924pubmed:pagination3484-8lld:pubmed
pubmed-article:9341924pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:9341924pubmed:meshHeadingpubmed-meshheading:9341924-...lld:pubmed
pubmed-article:9341924pubmed:meshHeadingpubmed-meshheading:9341924-...lld:pubmed
pubmed-article:9341924pubmed:meshHeadingpubmed-meshheading:9341924-...lld:pubmed
pubmed-article:9341924pubmed:meshHeadingpubmed-meshheading:9341924-...lld:pubmed
pubmed-article:9341924pubmed:meshHeadingpubmed-meshheading:9341924-...lld:pubmed
pubmed-article:9341924pubmed:meshHeadingpubmed-meshheading:9341924-...lld:pubmed
pubmed-article:9341924pubmed:meshHeadingpubmed-meshheading:9341924-...lld:pubmed
pubmed-article:9341924pubmed:meshHeadingpubmed-meshheading:9341924-...lld:pubmed
pubmed-article:9341924pubmed:meshHeadingpubmed-meshheading:9341924-...lld:pubmed
pubmed-article:9341924pubmed:meshHeadingpubmed-meshheading:9341924-...lld:pubmed
pubmed-article:9341924pubmed:meshHeadingpubmed-meshheading:9341924-...lld:pubmed
pubmed-article:9341924pubmed:meshHeadingpubmed-meshheading:9341924-...lld:pubmed
pubmed-article:9341924pubmed:meshHeadingpubmed-meshheading:9341924-...lld:pubmed
pubmed-article:9341924pubmed:year1997lld:pubmed
pubmed-article:9341924pubmed:articleTitleSynthesis, cardiotonic activity, and structure-activity relationships of 17 beta-guanylhydrazone derivatives of 5 beta-androstane-3 beta, 14 beta-diol acting on the Na+,K(+)-ATPase receptor.lld:pubmed
pubmed-article:9341924pubmed:affiliationDepartment of Medicinal Chemistry, Prassis Istituto di Ricerche Sigma-Tau, Settimo Milanese, MI, Italy.lld:pubmed
pubmed-article:9341924pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:9341924lld:chembl